Upper urinary tract infections in adults: about 261 episodes
##plugins.themes.academic_pro.article.main##
Abstract
Background : Upper urinary tract infections are frequent. Escherichia coli is the main pathogen identified from community acquired infections.
Aim : We aim to study epidemiologic, clinical and bacterial features of this infection.
Methods: We identified 261 episodes that occurred in 241 patients. They were 213 females and 48 males aged of 48,75 years. Enterobacteriaceae were the main pathogens isolated in 93,5%: E. coli in 73,3% and Klebsiella pneumoniae in 15,3%. E. coli sensitivity was of 30% for amoxicillin, 98% for cefotaxim, 96% for gentamicin, 90% for ciprofloxacine and 56% for co-trimoxazole. Anterior antibiotic use was associated with low E. coli sensitivity mainly with fluoroquinolones (96 vs 77%) and co-trimoxazole (62 vs 43%). This enhances the role of antibiotic pressure on the resistance emergence.
Conclusion: the reasonable use of antibiotics is necessary to limit resistance extent.
Keywords:
Upper urinary tract infection, Escherichia coli, enterobacteriaceae, bacterial resistance##plugins.themes.academic_pro.article.details##
References
- Betsy Foxman. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003;49:53- 70
- F.M.E Wagenlehner, W. Wieder, K.G. Naber. Emergence of antibiotic resistance amongst hospital-acquired urinary tract infections and pharmacokinetic /pharmacodynamic considerations. J Hosp Infect 2005 ;60:191-200
- Lindsay E. Nicolle. Urinary tract infection: traditional pharmacologic therapies. Am J Med 2002;113:35S-44S
- Allan Ronald. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002;113:14S-19S
- Tsai-Ling Lauderdale, L. Clifford McDonald, Yih-Ru Shiau and al. The status of antimicrobial resistance in Taiwan among Gram-negative pathogens: the Taiwan surveillance of antimicribial resistance (TSAR) program, 2000. Diag Microbiol Infect Dis 2004;48:211-219
- Selcuk Yüksel, Burcu Öztürk, Asli Kavaz and al. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Int J Antimicrob Agents 2006;28:413-416
- George G. Zhanel, Tamiko L. Hisanaga, Nancy M. Laing. Antibiotic resistance in Escherichia coli outpatients urinary isolates: final results from the North America urinary tract infection collaborative alliance (NAUTICA). Int J Antimicrob Agents 2006;27:468-475
- Leonid S. Stratchounski, Vladimir V. Rafaski. Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian federation: two multicentre studies, UTIAP-1 and UTIAP-2. Int J Antimicrob Agents 2006;28S:S4-S9
- Yilmaz Karaca, Nilay Coplu, Aysegül Gozalan, Ozgur Oncul, Burak E. Citil, Berrin Esen. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years. Int J Antimicrob Agents 2005;26:75-77
- Godfrey K.M Harding, George G. Zhanel, Lindsay E. Nicolle, Mary Cheang. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Eng J Med 2002;347:1576-1583
- Ann Stapleton. Urinary tract infections in patients with diabetes. Am J Med 2002;113:80S-84S
- F.M.E. Wagenlehner, K.G. Naber. Treatment of bacterial urinary tract infections: presence and future. Eur Urol 2006;49:235-244
- Sita Nys, T. van Merode, A.I.M. Bartelds, E.E. Stobberingh. Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture. J Antimicrob Chemother 2006;57:955-958
- A. Falcone, D. Amantea, A. Levato et al. outcomes of a pharmacoepidemiological survey on the antibiotic treatment of uncomplicated acute cystitis in community. Pharmacol Res 2006;53:193-196
- D.A. Talan, K.G Naber, J. Palou, D. Elkharrat. Extendedrelease ciprofloxacine for treatment of urinary tract infections. Int J Antimicrob Agents 2004;23S1:54-66